These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 35777906)

  • 1. The role of mild and asymptomatic infections on COVID-19 vaccines performance: A modeling study.
    Aguiar M; Van-Dierdonck JB; Mar J; Stollenwerk N
    J Adv Res; 2022 Jul; 39():157-166. PubMed ID: 35777906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Simulated Identification of Silent COVID-19 Infections Among Children and Estimated Future Infection Rates With Vaccination.
    Moghadas SM; Fitzpatrick MC; Shoukat A; Zhang K; Galvani AP
    JAMA Netw Open; 2021 Apr; 4(4):e217097. PubMed ID: 33890990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of mixed vaccination rollout strategy: A modelling study.
    Stollenwerk N; Estadilla CDS; Mar J; Bidaurrazaga Van-Dierdonck J; Ibarrondo O; Blasco-Aguado R; Aguiar M
    Infect Dis Model; 2023 Jun; 8(2):318-340. PubMed ID: 36945695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 vaccines that reduce symptoms but do not block infection need higher coverage and faster rollout to achieve population impact.
    Swan DA; Bracis C; Janes H; Moore M; Matrajt L; Reeves DB; Burns E; Donnell D; Cohen MS; Schiffer JT; Dimitrov D
    Sci Rep; 2021 Jul; 11(1):15531. PubMed ID: 34330945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative evaluation of the impact of vaccine roll-out rate and coverage on reducing deaths: insights from the first 2 years of COVID-19 epidemic in Iran.
    Ghafari M; Hosseinpour S; Rezaee-Zavareh MS; Dascalu S; Rostamian S; Aramesh K; Madani K; Kordasti S
    BMC Med; 2023 Nov; 21(1):429. PubMed ID: 37953291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers.
    Angel Y; Spitzer A; Henig O; Saiag E; Sprecher E; Padova H; Ben-Ami R
    JAMA; 2021 Jun; 325(24):2457-2465. PubMed ID: 33956048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of COVID-19 vaccine efficacy in older age groups.
    Sadarangani M; Abu Raya B; Conway JM; Iyaniwura SA; Falcao RC; Colijn C; Coombs D; Gantt S
    Vaccine; 2021 Apr; 39(15):2020-2023. PubMed ID: 33736921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to Resurgent COVID-19 Outbreaks Following Vaccine Rollouts: A Modeling Study.
    Neofotistos G; Angeli M; Mattheakis M; Kaxiras E
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effectiveness of Pfizer-BioNTech and Oxford-AstraZeneca Vaccines to Prevent Severe COVID-19 in Costa Rica: Nationwide, Ecological Study of Hospitalization Prevalence.
    Rosero-Bixby L
    JMIR Public Health Surveill; 2022 May; 8(5):e35054. PubMed ID: 35483079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hidden fraction of Polish population immune to SARS-CoV-2 in May 2021.
    Budziar W; Gembara K; Harhala M; Szymczak A; Jędruchniewicz N; Baniecki K; Pikies A; Nahorecki A; Hoffmann A; Kardaś A; Szewczyk-Dąbrowska A; Klimek T; Kaźmierczak Z; Witkiewicz W; Barczyk K; Dąbrowska K
    PLoS One; 2022; 17(2):e0253638. PubMed ID: 35113873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COVID-19 Vaccines May Not Prevent Nasal SARS-CoV-2 Infection and Asymptomatic Transmission.
    Bleier BS; Ramanathan M; Lane AP
    Otolaryngol Head Neck Surg; 2021 Feb; 164(2):305-307. PubMed ID: 33320052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough covid 19 infections after 2 doses of covid 19 vaccination and comparing severity between hospitalized and non hospitalized in tertiary care hospital.
    S M; Hr C
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EVALUATION OF COVID-19 VACCINES EFFICACY IN IRAQI PEOPLES.
    Jawad MJ; Jawad MJ; Hasan IS; Hassan SM; Fatima G; Hadi NR
    Wiad Lek; 2022; 75(4 pt 2):929-937. PubMed ID: 35633320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 epidemic in New York City: development of an age group-specific mathematical model to predict the outcome of various vaccination strategies.
    Li M; Zu J; Zhang Y; Ma L; Shen M; Li Z; Ji F
    Virol J; 2022 Mar; 19(1):43. PubMed ID: 35292054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Benefits of Vaccinating With the First Available COVID-19 Coronavirus Vaccine.
    Bartsch SM; O'Shea KJ; Wedlock PT; Strych U; Ferguson MC; Bottazzi ME; Randall SL; Siegmund SS; Cox SN; Hotez PJ; Lee BY
    Am J Prev Med; 2021 May; 60(5):605-613. PubMed ID: 33632650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study.
    Romero-Brufau S; Chopra A; Ryu AJ; Gel E; Raskar R; Kremers W; Anderson KS; Subramanian J; Krishnamurthy B; Singh A; Pasupathy K; Dong Y; O'Horo JC; Wilson WR; Mitchell O; Kingsley TC
    BMJ; 2021 May; 373():n1087. PubMed ID: 33980718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COVID-19 vaccines: concerns beyond protective efficacy and safety.
    Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
    Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Technical guidelines for seasonal influenza vaccination in China (2021-2022)].
    National Immunization Advisory Committee (NIAC) Technical Working Group (TWG) , Influenza Vaccination TWG
    Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Oct; 42(10):1722-1749. PubMed ID: 34814607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.